<DOC>
	<DOCNO>NCT01339949</DOCNO>
	<brief_summary>The objective study confirm safety establish effectiveness low voltage external beam radiosurgery use IRay System treatment subject recurrent leakage secondary neovascular Age-related Macular Degeneration ( AMD ) determine decrease number Lucentis injection require first 12 month study .</brief_summary>
	<brief_title>Study Evaluate Safety Effectiveness IRay Wet Age-related Macular Degeneration ( AMD ) Patients With Recurrent Leakage Secondary Choroidal Neovascularisation ( CNV )</brief_title>
	<detailed_description>The objective study confirm safety establish effectiveness low voltage external beam radiosurgery use IRay System treatment subject recurrent leakage secondary neovascular AMD determine decrease number Lucentis injection require first 12 month study .</detailed_description>
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Choroidal Neovascularization</mesh_term>
	<criteria>1 . Subjects must neovascular AMD , receive least 6 prior injection Lucentis Avastin exhibit one following : persist fluid despite 3 consecutive monthly injection anti VEGF , receive 4 prior injection 6 month period , receive 8 prior injection 12 month period . 2 . Subjects must need antiVEGF treatment due increase fluid persistent cyst OCT , leakage FA . 3 . Subjects must total lesion size ≤12 disc area CNV lesion great linear dimension ≤6 mm , great 3 mm center fovea furthest point lesion perimeter . 4 . Subjects must sign ( give ) copy inform consent form , willing able return schedule treatment followup examination 3year duration study . 5 . Subjects must least 50 year age . 6 . Women must postmenopausal ≥1 year surgically sterilize , pregnancy screen must perform prior study reliable form contraception approve investigator must maintain study . 7 . Subjects must best correct visual acuity 75 25 letter study eye least 20 letter fellow eye . 1 . CNV due cause AMD , include ocular histoplasmosis syndrome , angioid streak , multifocal choroiditis , choroidal rupture , pathologic myopia ( spherical equivalent ≥8 diopter ) . 2 . A globe axial length &lt; 20 mm &gt; 26 mm . 3 . Evidence uncontrolled diabetes determine HbA1c &gt; 6.5 % and/or retinal finding consistent diabetic retinopathy . 4 . Prior concurrent therapy age relate macular degeneration include submacular surgery , subfoveal thermal laser photocoagulation ( without photographic evidence ) , transpupillary thermotherapy ( TTT ) , ocular photodynamic therapy study eye . 5 . History radiation head region study eye .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>AMD</keyword>
	<keyword>wet AMD</keyword>
	<keyword>Macular Degeneration</keyword>
	<keyword>wet Age-related Macular Degeneration</keyword>
	<keyword>Age-Related Macular Degeneration</keyword>
	<keyword>IRay</keyword>
	<keyword>radiation</keyword>
	<keyword>Oraya</keyword>
	<keyword>Oraya Therapeutics , Inc</keyword>
	<keyword>Low-voltage stereotactic radiosurgery</keyword>
	<keyword>radiosurgery</keyword>
	<keyword>x-ray</keyword>
	<keyword>Lucentis</keyword>
	<keyword>external beam radiation</keyword>
</DOC>